Skip to main content

Table 3 Baseline HIV prevalence/incidence, stability/instability and responsiveness/resistance patterns across communities by HPTN 071 (PopART) study arm

From: How ‘place’ matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa

Arm/site/triplet Baseline HIV prevalence HIV incidence* Stability/instability Responsiveness/resistance
ARM A
 Z2 Triplet 1 16.30% (14.2, 18.7) 1.64 (1.09, 2.38) Mixed Resistant
 Z5 Triplet 2 17.40% (15.8, 19.2) 1.57 (1.08, 2.2) Unstable Mixed
 Z8 Triplet 3 18.30% (16.5, 20.3) 1.36 (0.86, 2.04) Stable Resistant
 Z10 Triplet 4 25.90% (23.9, 28) 1.93 (1.39, 2.62) Unstable Resistant
 S14 Triplet 5 29.90% (28, 31.9) 2.36 (1.65, 3.27) Mixed Resistant
 S16 Triplet 6 24.90% (23.1, 26.9) 1.43 (0.93, 2.1) Unstable Resistant
 S19 Triplet 7 10.8% 0.5% Unstable Resistant
ARM B
 Z1 Triplet 1 17.0% (14.7, 19.4) 0.94 (0.57, 1.48) Stable Responsive
 Z6 Triplet 2 23.4% (21.7, 25.1) 1.2 (0.8, 1.72) Stable Mixed
 Z9 Triplet 3 21.5% (19.4, 23.7) 1.3 (0.81, 1.97) Mixed Mixed
 Z11 Triplet 4 24.2% (22.1, 26.4) 1.13 (0.68, 1.76) Mixed Mixed
 SA13 Triplet 5 29.2% (27.4, 31.1) 1.8 (1.24, 2.53) Mixed Resistant
 SA18 Triplet 6 19.9% (18.3, 21.5) 1.24 (0.81, 1.82) Mixed Responsive
 SA20 Triplet 7 9.9% (8.7, 11.3) 0.4 (0.19, 0.74) Stable Responsive
ARM C
 Z3 Triplet 1 21.9% (20, 23.9) 1.17 (0.75, 1.74) Stable Mixed
 Z4 Triplet 2 18.1% (16.4, 20) 1.48 (1.02, 2.07) Stable Responsive
 Z7 Triplet 3 19.6% (18, 21.4) 1.63 (1.1, 2.33) Mixed Resistant
 Z12 Triplet 4 28.1% (25.5, 30.9) 2.39 (1.69, 3.29) Unstable Mixed
 SA15 Triplet 5 28.0% (26, 30.1) 2.15 (1.43, 3.1) Mixed Resistant
 SA17 Triplet 6 35.7% (33.6, 37.8) 2.31 (1.58, 3.27) Unstable Resistant
 SA21 Triplet 7 3.0% (2.2, 4) 0.65 (0.36, 1.09) Stable Resistant
  1. *HIV incidence confidence intervals were wide since incidence estimates for individual communities were based on small numbers of events